Fidelity Biosciences - Lihan Sun, Ph.D.

Stephen Knight, M.D.
Robert Weisskoff, Ph.D.
Hingge Hsu, M.D.
Mary Bevelock Pendergast
Ben Auspitz
Thomas R. Beck, M.D.
Wei Li, Ph.D.
Jon Lim
Alex Pasteur, Ph.D.
Ketan Patel, M.D.
Jim Case
Melissa Packard
Eric Golding, M.D.
Lihan Sun, Ph.D.
Andrew Hedin
Carl Byers
Declan Doogan, M.D.
Jim Dougherty
Baruch Harris, Ph.D.

1 Main Street, 13th Floor
Cambridge, MA 02142

phone: +1 617 231 2400

fax: +1 617 231 2425

Lihan Sun, Ph.D.

Senior Analyst

Dr. Sun joined Fidelity Biosciences in 2012. Prior to joining, Dr. Sun was a Senior Associate Consultant at L.E.K. Consulting in the healthcare practice. At L.E.K. Consulting, Dr. Sun specialized in corporate growth strategies, portfolio management, commercial opportunity assessment, competitive analysis and M&A advisory for large pharmaceutical and medical device companies, as well as leading private equity firms.

Dr. Sun holds a Ph.D. in Molecular Pharmacology from Stanford University School of Medicine. His graduate research was focused on developing novel therapeutics for heart attack and congestive heart failure. He received his B.S. in Biology with Distinction from Yale University.